Owens & Minor logo
Owens & Minor OMI

Quarterly report 2026-Q1
added 05-11-2026

report update icon

Owens & Minor Financial Statements 2011-2026 | OMI

Annual Financial Statements Owens & Minor

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007

Market Cap

- 742 M 1.63 B 1.14 B 3.21 B 2.15 B 404 M 460 M 1.34 B 2.17 B 2.15 B 2.13 B 2.2 B 1.94 B 1.91 B - - - -

Shares

76.9 M 76.7 M 75.8 M 74.5 M 72.7 M 63.4 M 60.6 M 60 M 60 M 61.1 M 62.1 M 62.2 M 62.6 M 62.8 M 62.8 M 62.3 M 61.7 M - -

Historical Prices

- 9.67 21.4 15.4 44.1 34 6.82 6.14 15.2 32.4 34.5 30.3 28.7 24.4 23.3

Net Income

-1.1 B -363 M -41.3 M 22.4 M 222 M 29.9 M -62.4 M -437 M 72.8 M 109 M 103 M 66.5 M 111 M 109 M 115 M 111 M 105 M 93.3 M -

Revenue

2.76 B 2.68 B 2.55 B 9.96 B 9.79 B 8.48 B 9.21 B 9.84 B 9.32 B 9.72 B 9.77 B 9.44 B 9.07 B 8.91 B 8.63 B - - - -

Cost of Revenue

1.47 B 1.4 B 1.34 B 8.13 B 8.27 B 7.2 B 8.08 B 8.35 B 8.15 B 8.54 B - - - - - - - - -

Gross Profit

- 2.22 B 2.13 B 1.83 B 1.51 B 1.28 B 1.13 B 1.37 B 1.17 B 1.19 B 1.21 B 1.17 B 1.12 B 925 M 858 M 808 M 814 M 741 M -

Operating Income

27.5 M -218 M 133 M 143 M 368 M 204 M 73.2 M -352 M 89.3 M 200 M 200 M 160 M 198 M 197 M 204 M 196 M 201 M 181 M -

Interest Expense

107 M 108 M 117 M 129 M 48.1 M 83.4 M 98.1 M 71 M 31.8 M 27.1 M 27.1 M 18.2 M 13.1 M 13.4 M 13.7 M 14.3 M 13 M 16 M -

EBITDA

242 M -36.4 M 344 M 372 M 459 M 297 M 220 M 212 M 209 M 280 M 289 M 259 M 261 M 247 M 238 M 225 M 227 M 203 M -

Operating Expenses

- - - - - - 1.03 B 1.26 B 1.02 B 963 M 986 M 968 M 907 M 718 M 654 M - - - -

General and Administrative Expenses

1.07 B 1.08 B 1 B 1.55 B 1.08 B 1.04 B 1.02 B 1.26 B 1.02 B 970 M 934 M 927 M 864 M 683 M 611 M 564 M 592 M 545 M -

All numbers in USD currency

Quarterly Income Statement Owens & Minor

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1 2010-Q3 2010-Q2

Shares

76.4 M 77.3 M 76.9 M 77.3 M 77.2 M 77.1 M 76.7 M 76.3 M 76.5 M 76.2 M 75.8 M 75.2 M 76.3 M 74.9 M 74.7 M 73.6 M 75.4 M 73.2 M 72.8 M 70.8 M 73.5 M 60.8 M 61.1 M 60.6 M 62.8 M 60 M 59.8 M 60.4 M 61.5 M 59.8 M 59.8 M 60 M 61.5 M 59.8 M 59.9 M 60 M 61 M 61 M 61.5 M 61.7 M 62.8 M 62 M 62.2 M 62.3 M 63.1 M 62.2 M 62.3 M 62.3 M 63.1 M 62.6 M 62.7 M 62.7 M 63.3 M 62.8 M 62.8 M 62.8 M 63.4 M 62.8 M 63 M 62.6 M 63.5 M 63.5 M

Net Income

-6.47 M -150 M -869 M -25 M - -12.8 M -31.9 M -21.9 M - -6.43 M -28.2 M -24.4 M - 12.5 M 28.6 M 39.3 M - 44.1 M 65.9 M 69.6 M - 46.1 M -55.6 M -11.3 M - 1.22 M -10.5 M -14.1 M - -565 K -183 M 8.15 M - 10.9 M 20.1 M 18.8 M - 29.8 M 27.7 M 24.1 M - 28.2 M 24.2 M 18.9 M - 7.16 M 19.9 M 25.5 M - 28 M 28.9 M 26.1 M - 24.6 M 30.1 M 29.4 M - 33.4 M 29.2 M 28.7 M 31.5 M 29.5 M

Revenue

628 M 697 M 682 M 2.63 B - 2.72 B 660 M 2.61 B - 2.59 B 2.56 B 2.52 B - 2.5 B 2.5 B 2.41 B - 2.5 B 2.49 B 2.33 B - 2.19 B 1.81 B 2.12 B - 2.29 B 2.38 B 2.35 B - 2.46 B 2.46 B 2.37 B - 2.33 B 2.27 B 2.33 B - 2.42 B 2.48 B 2.46 B - 2.47 B 2.42 B 2.39 B - 2.39 B 2.31 B 2.26 B - 2.27 B 2.24 B 2.25 B - 2.18 B 2.19 B 2.22 B - 2.18 B 2.13 B 2.12 B - -

Cost of Revenue

350 M 375 M 357 M 2.11 B - 2.16 B 344 M 2.08 B - 2.05 B 2.04 B 2.03 B - 1.98 B 1.97 B 2.03 B - 2.17 B 2.09 B 1.88 B - 1.84 B 1.54 B 1.85 B - 2.01 B 2.09 B 2.07 B - 2.11 B 2.13 B 2.05 B - 2.03 B - - - - - - - - - - - - - - - - - - - - - - - - - - 1.87 B 1.83 B

Gross Profit

- - - 526 M - 560 M 544 M 536 M - 538 M 519 M 497 M - 513 M 533 M 373 M - 329 M 400 M 443 M - 344 M 269 M 269 M - 281 M 287 M 277 M - 353 M 325 M 325 M - 302 M 274 M 281 M - 296 M 299 M 297 M - 306 M 298 M 298 M - 292 M 282 M 281 M - 273 M 273 M 279 M - 228 M 211 M 214 M - 217 M 216 M 211 M 198 M 192 M

Operating Income

17.1 M 26.5 M -39.7 M 124 K - 24.2 M 16.9 M 9.7 M - 23.8 M 10.8 M 9.81 M - 60.2 M 75.1 M 61.1 M - 62.9 M 96.9 M 147 M - 75.6 M 22.2 M 10.8 M - 26.1 M 15.9 M 16.6 M - 21.4 M -172 M 24.2 M - 29.7 M 32.8 M 35.5 M - 53.6 M 52.1 M 45 M - 53.6 M 47.9 M 41 M - 35.4 M 37.1 M 46.3 M - 49.2 M 50 M 47.9 M - 46.7 M 53.2 M 51.9 M - 58.5 M 51 M 51 M 55.3 M 52.2 M

Interest Expense

- 29 M 26 M 34 M - 36.6 M 25.6 M 35.7 M - 38.1 M 40.7 M 42.2 M - 39.9 M 35.8 M 12 M - 11.6 M 11.5 M 13.7 M - 21 M 21.6 M 23.3 M - 24 M 26 M 25.5 M - 23.8 M 18.6 M 10.3 M - 8.74 M 6.74 M 6.74 M - 6.77 M 6.76 M 6.79 M - 6.74 M 6.68 M 6.88 M - 4.3 M 3.34 M 3.25 M - 3.39 M 3.25 M 3.2 M - 3.07 M 3.49 M 3.42 M - 3.43 M 3.02 M 3.72 M 3.76 M 3.5 M

EBITDA

78.9 M 211 M -32.1 M 61.3 M - 85.8 M 26.9 M 83.8 M - 97.5 M 82.9 M 80.7 M - 118 M 148 M 85.2 M - 85.5 M 119 M 170 M - 96.2 M 47.1 M 34.7 M - 55.4 M 46.1 M 45.3 M - 51.1 M -146 M 42.1 M - 45.5 M 45.5 M 48.1 M - 67.4 M 66.2 M 59.2 M - 69 M 63.6 M 60.1 M - 77 M 64.9 M 60.1 M - 61.7 M 62.3 M 60.5 M - 56.8 M 61.7 M 60.4 M - 66.9 M 59.3 M 59.8 M 62.8 M 59.3 M

General and Administrative Expenses

255 M 266 M 268 M 462 M - 470 M 270 M 478 M - 453 M 455 M 449 M - 431 M 422 M 269 M - 262 M 294 M 293 M - 263 M 242 M 254 M - 249 M 264 M 255 M - 325 M 309 M 284 M - 261 M 237 M 238 M - 241 M 243 M 243 M - 247 M 247 M 250 M - 231 M 226 M 226 M - 211 M 213 M 218 M - 165 M 150 M 156 M - 153 M 156 M 151 M 135 M 134 M

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Owens & Minor OMI
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Owens & Minor plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical distribution industry

Issuer Price % 24h Market Cap Country
AmerisourceBergen Corporation AmerisourceBergen Corporation
ABC
- -0.23 % $ 37.5 B usaUSA
Henry Schein Henry Schein
HSIC
$ 73.9 -0.42 % $ 8.93 B usaUSA
PPD, Inc. PPD, Inc.
PPD
- 0.13 % $ 16.6 B usaUSA
Prestige Consumer Healthcare Prestige Consumer Healthcare
PBH
$ 48.02 0.04 % $ 2.33 B usaUSA
Patterson Companies Patterson Companies
PDCO
- -0.87 % $ 3 B usaUSA
Cardinal Health Cardinal Health
CAH
$ 200.37 -0.15 % $ 48.3 B usaUSA
McKesson Corporation McKesson Corporation
MCK
$ 754.4 -1.52 % $ 121 B usaUSA